# Euthymics Bioscience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/euthymics-bioscience

- Industry: Pharmaceuticals
- Headquarters: Cambridge, US
- Website: www.euthymics.com
- Total disclosed funding: $31M
- Latest round: Series A (Nov 20, 2012)
- Investors on record: 5

## About

Euthymics Bioscience is based in US and operates as a neuroscience-focused, clinical-stage biopharmaceutical company.

## Funding rounds

- Series A, Nov 20, 2012, $3M — Venture Investors, GBS Venture Partners, Novartis Venture Fund, Tekla Capital Management
- Series A, May 15, 2012, $3.7M — Venture Investors, GBS Venture Partners, Novartis Venture Fund, Tekla Capital Management
- Series A, Jul 22, 2010, $24M — Venture Investors, GBS Venture Partners, Novartis Venture Fund, State of Wisconsin Investment Board, Tekla Capital Management

## Investors

- Venture Investors — Series A
- GBS Venture Partners (https://capitalatlas.ai/funds/gbs-venture-partners) — Series A
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A
- State of Wisconsin Investment Board — Series A
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series A